Population pharmacokinetic analysis of long-acting naltrexone for injection.

被引：0
|
作者：
Hayes, S
Farrell, C
Dunbar, J
Turncliff, R
机构：
[1] GlocoMax, Marlow, Bucks, England
[2] Alkermes Inc, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.103
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P28 / P28
页数：1
相关论文
共 50 条
  • [1] Long-acting naltrexone injection for opioid use disorder
    Kang, Seema
    [J]. LANCET PSYCHIATRY, 2018, 5 (12): : 967 - 967
  • [2] Population pharmacokinetic modeling of long-acting microsphere formulations of risperidone
    Niu, Jing
    Kotakonda, Harish Kaushik
    Yellu, Narsimha Reddy
    Gobburu, Jogarao
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S61 - S61
  • [3] REVIEW OF NALTREXONE, A LONG-ACTING OPIATE ANTAGONIST
    CRABTREE, BL
    [J]. CLINICAL PHARMACY, 1984, 3 (03): : 273 - 280
  • [4] Long-acting naltrexone has long-acting benefits and 100% induction rates are not difficult to achieve
    Brewer, Colin
    Streel, Emmanuel
    [J]. ADDICTION, 2019, 114 (01) : 188 - 189
  • [5] Long-acting risperidone injection
    Love, RC
    Conley, RJ
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (17) : 1792 - 1800
  • [6] POPULATION PHARMACOKINETIC MODELING AND SIMULATIONS OF LONG-ACTING INTRAMUSCULAR RISPERIDONE ISM®
    Winkler, J.
    Snoeck, E.
    Llaudo Garin, J.
    Ayani, I.
    Martinez-Gonzalez, J.
    Aduriz, I. Gutierro
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E3 - E4
  • [7] COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Carroll, S. M.
    Jemiai, N.
    Suter, B.
    O'Donohoe, P.
    Skjoldborg, U.
    Moller, J.
    Kleivenes, O. K.
    Novick, D.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A358 - A358
  • [8] Characteristics Associated with Long-Acting Naltrexone Treatment Persistence
    Chang, Grace
    Schein, Abigail
    Crawford, Mitchell
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (04): : 273 - 274
  • [9] The preclinical development of Medisorb® naltrexone, a once a month long-acting injection, for the treatment of alcohol dependence
    Dean, RL
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 643 - 655
  • [10] Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling
    Bandin-Vilar, Enrique
    Toja-Camba, Francisco Jose
    Vidal-Millares, Maria
    Duran-Maseda, Maria Jose
    Pou-Alvarez, Marta
    Castro-Balado, Ana
    Maronas, Olalla
    Gil-Rodriguez, Almudena
    Carracedo, Angel
    Zarra-Ferro, Irene
    Soy, Dolors
    Fernandez-Ferreiro, Anxo
    Mangas-Sanjuan, Victor
    Mondelo-Garcia, Cristina
    [J]. PSYCHIATRY RESEARCH, 2024, 333
12345